Lataa...
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
Recombinant factor VIIa (rFVIIa) can be used for rapid INR normalization in life-threatening hemorrhage in anticoagulated patients. Dosing is unclear and may carry thromboembolic risks. We reviewed the use of rFVIIa at a comprehensive stroke and cerebrovascular center to evaluate dose effectiveness...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155054/ https://ncbi.nlm.nih.gov/pubmed/25197623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-471 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|